•Signs Point to Affy Pharma Drug Rejectionat TheStreet(Mon 4:22PM EDT)
jmorg1964, how can someone your age be so immature?
The SEC must love you.
j morg is an idiot. spam.
street.com is a blog. who the heck is A.F. ? a no body. jim cramer, a self described entertainer. thats it.
YOUR AN IDIOT!!!!!!
Jmorg you tool .... Signs Point to MAP Pharma Drug Rejection TheStreet.com - 56 minutes ago
Baird Continues to Recommend Affymax (AFFY) Ahead of Tomorrow's PDUFA DateMarch 26, 2012 7:43 AM EDT Baird is reiterating its Outperform rating and $15 price target on Affymax, Inc. (NASDAQ: AFFY)AFFY Hot Sheet and continues to Rating Summary: recommend 6 Buy, 0 Hold, 0 Sell purchase into Tuesday's PDUFARating Trend: date.Today